General MM

SOHO 2019 | Which classes of drugs are used for non-antibody based immunotherapies in MM?

L: English

During SOHO 2019, Houston, US, the Multiple Myeloma Hub were pleased to talk with Dr Nina Shah from University of California, San Francisco, US, about different classes of drugs used as non-antibody based immunotherapies in multiple myeloma.
Dr Shah highlights promising results of CAR T-cells, bispecific T-cell engagers (BiTEs), and antibody-drug conjugates.